COM:HEPIONPHARMA
Hepion Pharmaceuticals
- Stock
Last Close
0.69
22/11 21:00
Market Cap
5.64M
Beta: -
Volume Today
19.61K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '14 | Jun '15 | Jun '16 | Jun '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | |||||||||||
average payables | 123.76K - | 862.64K 597.05% | 2.87M 232.33% | 2.94M 2.54% | 1.19M 59.60% | 619.99K 47.79% | 2.11M 239.84% | 3.08M 46.38% | 2.56M 17.13% | 2.51M 1.90% | |
average receivables | |||||||||||
book value per share | -2.56K - | 1.77K 169.07% | 545.36 69.20% | 1.74K 219.16% | 10.74 99.38% | 158.40 1,374.73% | 83.74 47.14% | 26.46 68.40% | 0.65 97.53% | 1.83 180.35% | |
capex per share | -13.85 - | -42.88 209.54% | -2.73 93.63% | -2.83 3.42% | -0.50 - | -0.18 63.91% | -0.04 79.59% | -0.00 99.42% | -0.00 1,580.95% | ||
capex to depreciation | -12.00 - | -5.09 57.56% | -0.31 93.97% | -0.53 71.29% | -1.93 - | -2.55 32.42% | -1.52 40.57% | -0.21 86.08% | -0.21 1.03% | ||
capex to operating cash flow | 0.01 - | 0.01 25.95% | 0.00 95.37% | 0.00 92.36% | 0.01 - | 0.01 20.00% | 0.00 23.27% | 0.00 88.81% | 0.00 25.13% | ||
capex to revenue | |||||||||||
cash per share | 1.59K - | 2.35K 47.88% | 3.06K 30.42% | 2.49K 18.59% | 15.40 99.38% | 136.28 784.74% | 84.17 38.24% | 25.99 69.12% | 0.67 97.42% | 3.72 454.52% | |
days of inventory on hand | |||||||||||
days payables outstanding | |||||||||||
days sales outstanding | |||||||||||
debt to assets | 0.00 - | 0.18 - | 0.04 77.53% | 0.02 60.87% | 0.00 80.20% | 0.00 41.86% | 0.01 549.01% | ||||
debt to equity | 0.01 - | 0.73 - | 0.05 93.16% | 0.02 62.80% | 0.00 81.64% | 0.00 36.90% | 0.03 1,234.80% | ||||
dividend yield | 0.07 - | 0.06 - | 0.01 79.18% | 0.00 96.48% | 0.00 70.91% | 0.00 92.04% | 0.00 611.73% | ||||
earnings yield | -0.37 - | -0.13 65.03% | -0.60 365.17% | -0.44 27.08% | -0.13 70.45% | -0.61 371.31% | -0.96 56.54% | -0.41 57.47% | -0.09 77.43% | -3.80 4,025.83% | |
enterprise value | 12.40M - | 105.93M 753.96% | 20.75M 80.41% | 20.82M 0.36% | 71.20M 241.95% | -2.16M 103.04% | -18.78M 767.95% | -10.90M 41.96% | 406.70M 3,831.30% | -1.71M 100.42% | |
enterprise value over ebitda | 6.44 - | -7.81 221.27% | -0.84 89.20% | -0.83 2.15% | -3.63 339.29% | 0.27 107.53% | 0.93 241.93% | 0.36 61.50% | -9.34 2,698.11% | 0.04 100.38% | |
ev to operating cash flow | -9.10 - | -10.95 20.34% | -1.25 88.56% | -1.09 13.34% | -4.55 319.02% | 0.29 106.28% | 1.16 306.18% | 0.35 69.95% | -11.63 3,432.50% | 0.04 100.36% | |
ev to sales | |||||||||||
free cash flow per share | -1.21K - | -5.02K 316.77% | -6.86K 36.46% | -3.69K 46.22% | -85.09 97.69% | -74.55 12.38% | -33.59 54.95% | -8.92 73.44% | -0.46 94.86% | -10.30 2,144.98% | |
free cash flow yield | -0.10 - | -0.09 8.93% | -0.59 566.54% | -0.57 3.56% | -0.22 62.03% | -0.70 222.68% | -0.77 10.27% | -0.39 48.98% | -0.08 80.48% | -3.18 4,061.52% | |
graham net net | -2.72K - | 1.35K 149.62% | -1.82K 234.28% | 702.54 138.71% | -18.39 102.62% | 94.68 614.83% | 67.37 28.84% | 22.99 65.88% | 0.54 97.67% | 1.00 86.90% | |
graham number | 16.32K - | 17.16K 5.14% | 9.29K 45.85% | 10.59K 13.93% | 111.44 98.95% | 484.14 334.43% | 281.52 41.85% | 74.46 73.55% | 2.85 96.17% | 22.55 689.93% | |
income quality | 0.26 - | 0.67 161.18% | 0.97 44.47% | 1.29 32.20% | 1.66 28.61% | 1.13 32.00% | 0.79 29.46% | 0.95 20.15% | 0.83 13.18% | 0.84 0.88% | |
intangibles to total assets | 0 - | 0 | 0.39 Infinity% | 0.28 28.71% | 0.62 124.50% | 0.25 59.92% | 0.10 58.00% | 0.05 53.02% | 0.05 8.34% | 0 100% | |
interest coverage | -0.46 - | -35.99 7,667.07% | 5.47 115.19% | 4.98 8.95% | 1.51 69.66% | -14.00 1,027.24% | -645.11 4,507.85% | -3.43K 431.99% | -4.48K 30.41% | 5.12K 214.37% | |
interest debt per share | 3.15K - | 199.74 93.67% | -1.57K 886.70% | -811.84 48.34% | -44.74 94.49% | 13.34 129.81% | 1.62 87.86% | 0.09 94.27% | 0.00 98.34% | 0.05 3,163.38% | |
inventory turnover | |||||||||||
invested capital | 0.01 - | 0.73 - | 0.05 93.16% | 0.02 62.80% | 0.00 81.64% | 0.00 36.90% | 0.03 1,234.80% | ||||
market cap | 14.22M - | 110.49M 676.90% | 28.14M 74.53% | 33.81M 20.13% | 72.60M 114.75% | 10.95M 84.91% | 21.19M 93.53% | 80.13M 278.08% | 457.83M 471.35% | 12.87M 97.19% | |
net current asset value | -2.95M - | 3.31M 212.01% | -3.89M 217.78% | 3.87M 199.28% | -3.25M 183.96% | 10.14M 412.33% | 34.51M 240.38% | 86.89M 151.80% | 46.11M 46.94% | 6.67M 85.52% | |
net debt to ebitda | -0.94 - | 0.34 135.65% | 0.30 10.68% | 0.51 71.21% | 0.07 86.22% | 1.66 2,233.97% | 1.99 20.07% | 3.00 51.07% | 1.17 60.89% | 0.30 74.38% | |
net income per share | -4.62K - | -7.39K 60.05% | -7.04K 4.77% | -2.86K 59.33% | -51.39 98.20% | -65.77 27.98% | -42.06 36.04% | -9.31 77.86% | -0.55 94.06% | -12.32 2,125.72% | |
operating cash flow per share | -1.19K - | -4.98K 318.02% | -6.85K 37.58% | -3.68K 46.24% | -85.09 97.69% | -74.05 12.97% | -33.41 54.89% | -8.88 73.41% | -0.46 94.84% | -10.30 2,145.24% | |
payables turnover | |||||||||||
receivables turnover | |||||||||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | -2.64 - | -2.67 1.10% | -2.11 20.82% | -1.12 47.10% | -3.02 170.27% | -0.44 85.53% | -0.47 6.85% | -0.33 28.84% | -0.74 122.57% | -2.70 265.57% | |
revenue per share | |||||||||||
roe | 1.80 - | -4.17 331.73% | -12.90 209.24% | -1.64 87.26% | -4.78 191.02% | -0.42 91.32% | -0.50 20.99% | -0.35 29.93% | -0.85 140.49% | -6.72 693.90% | |
roic | 0.96 - | -4.17 534.43% | -12.06 189.37% | -2.06 82.95% | -4.04 96.56% | -0.37 90.87% | -0.48 30.61% | -0.32 32.63% | -0.85 162.09% | -6.52 666.14% | |
sales general and administrative to revenue | |||||||||||
shareholders equity per share | -2.56K - | 1.77K 169.07% | 545.36 69.20% | 1.74K 219.16% | 10.74 99.38% | 158.40 1,374.73% | 83.74 47.14% | 26.46 68.40% | 0.65 97.53% | 1.83 180.35% | |
stock based compensation to revenue | |||||||||||
tangible asset value | -2.93M - | 3.44M 217.25% | -3.74M 208.85% | 4.00M 206.77% | -3.09M 177.21% | 11.12M 460.41% | 35.46M 218.83% | 87.93M 147.98% | 46.67M 46.93% | 7.28M 84.40% | |
tangible book value per share | -2.56K - | 1.77K 169.07% | -1.55K 187.49% | 768.05 149.57% | -16.78 102.19% | 108.86 748.69% | 73.28 32.69% | 25.02 65.86% | 0.61 97.55% | 1.83 199.52% | |
working capital | 1.52M - | 3.31M 117.03% | 2.81M 14.97% | 10.25M 264.51% | 118.17K 98.85% | 13.14M 11,016.75% | 37.97M 189.05% | 89.25M 135.03% | 48.61M 45.53% | 12.20M 74.91% |
All numbers in USD (except ratios and percentages)